PFEbusinesswire

Trial Date Has Been Set in MDL against Pfizer for Depo-Provera Overseen by Levin Papantonio

Summary

PENSACOLA, Fla.--(BUSINESS WIRE)--At a Case Management Conference in the Multi District Litigation against Pfizer Inc. (NYSE:PFE), the Honorable M. Casey Rodgers set a date for the first Trial, which will take place in December 2026, as more than 2,100 women pursue litigation alleging Pfizer failed to adequately warn patients despite long-standing knowledge of the risk. The hearing took place within days of the The US Food and Drug Administration (FDA) approving a label change to Pfizer’s contr

Original Article

Read the full article from the original source for complete details and context.

Read Full Article

Article published on January 7, 2026 by businesswire

    Trial Date Has Been Set in MDL against Pfizer for Depo-Provera Overseen by Levin Papantonio | PFE Stock News | Candlesense